Heterocyclidene acetamide derivative

Details Heterocyclidene acetamide derivative Heterocyclidene acetamide derivative

2011-03-22

2011-03-22

Chandrakumar, Nizal S (Department: 1625)

Organic compounds -- part of the class 532-570 series

Organic compounds

Heterocyclic carbon compounds containing a hetero ring...

C549S356000

Reexamination Certificate

active

07910751

ABSTRACT:
A compound represented by formula (I′):(wherein m, n, and p each represent 0 to 2; q represents 0 or 1; R1represents halogen, a hydrocarbon group, a heterocyclic group, an alkoxy group, an alkoxycarbonyl group, a sulfamoyl group, a CN group, an NO2group, or the like; R2represents halogen, amino, a hydrocarbon group, an aromatic heterocyclic group, or an oxo group; X1represents O, —NR3—, or —S(O)r-; X2represents a methylene group, O, —NR3—, or —S(O)r-; Q′ represents a heteroaryl group, a heteroarylalkyl group, a substituted aryl group, or an aralkyl group; Cycle moiety represents an aryl ring or a heteroaryl ring; and the wavy line represents an E-isomer or a Z-isomer), a salt of the compound, or a solvate of the compound or the salt. A pharmaceutical composition and a transient receptor potential type I (TRPV1) receptor antagonist each contain, as an active ingredient, at least one of the compound, a salt of the compound, and a solvate of the compound or the salt.

REFERENCES:
patent: 4977166 (1990-12-01), Hardy et al.
patent: 5710150 (1998-01-01), Taniguchi et al.
patent: 6120964 (2000-09-01), Wilson et al.
patent: 6340678 (2002-01-01), Matsuhisa et al.
patent: 2004/0038969 (2004-02-01), Doherty et al.
patent: 2004/0204477 (2004-10-01), Moll et al.
patent: 2005/0004103 (2005-01-01), Koshio et al.
patent: 2006/0035882 (2006-02-01), Koga et al.
patent: 2007/0167444 (2007-07-01), Kuramochi et al.
patent: 2008/0287428 (2008-11-01), Uchida et al.
patent: 2010/0016285 (2010-01-01), Uchida et al.
patent: 0 411 751 (1991-02-01), None
patent: 1 109 071 (2001-06-01), None
patent: 1 619 185 (2006-01-01), None
patent: 1 829 864 (2007-09-01), None
patent: A-4-178381 (1992-06-01), None
patent: 05-339223 (1993-12-01), None
patent: A-9-221475 (1997-08-01), None
patent: A-2001-213870 (2001-08-01), None
patent: A-2005-187449 (2005-07-01), None
patent: WO 94/26692 (1994-11-01), None
patent: WO 95-06035 (1995-03-01), None
patent: WO 97/12870 (1997-04-01), None
patent: WO 98/07704 (1998-02-01), None
patent: WO 98/39325 (1998-09-01), None
patent: WO 98/42673 (1998-10-01), None
patent: WO 03/042181 (2003-05-01), None
patent: WO 03/049702 (2003-06-01), None
patent: WO 2004/052846 (2004-06-01), None
patent: WO 2004/056774 (2004-07-01), None
patent: WO 2004/069792 (2004-08-01), None
patent: WO 2004/100865 (2004-11-01), None
patent: WO 2004/110986 (2004-12-01), None
patent: WO 2005/016922 (2005-02-01), None
patent: WO 2005/030766 (2005-04-01), None
patent: WO 2005/040100 (2005-05-01), None
patent: WO 2005/040119 (2005-05-01), None
patent: WO 2005/040121 (2005-05-01), None
patent: WO 2005/046683 (2005-05-01), None
patent: WO 2005/070885 (2005-08-01), None
patent: WO 2005/095329 (2005-10-01), None
patent: WO 2006/006741 (2006-01-01), None
patent: WO 2006/038871 (2006-04-01), None
patent: WO 2006/058338 (2006-06-01), None
patent: WO 2006/064075 (2006-06-01), None
patent: WO 2007/010383 (2007-01-01), None
patent: WO 2008/091021 (2008-07-01), None
patent: WO 2010/010933 (2010-01-01), None
patent: WO 2010/010934 (2010-01-01), None
patent: WO 2010/010935 (2010-01-01), None
patent: WO 2010/038803 (2010-04-01), None
Dorwald F. A. Side Reactions in Organic Synthesis, 2005, Wiley: VCH, Weinheim p. IX of Preface p. 1-15.
West, Solid State Chemistry and its applications, John Wiley & Sons, 1984, p. 358.
Di Fabio et al., “Benzoazepine derivative as potent antagonists of the glycine binding site associated to the NMDA receptor,”Il Farmaco, vol. 58, No. 9, 2003, pp. 723-738.
Messeri et al., “Efficient synthesis of novel benzo-[e]-[1,4]-diazepine derivatives,”Tetrahedron Letters, vol. 42, No. 18, 2001, pp. 3227-3230.
Matsuhisa et al., “Nonpeptide Arginine Vasopressin Antagonists for Both V1Aand V2Receptors: Synthesis and Pharmacological Properties of 4′-[5-(Substituted Methylidene)-2,3,4,5-tetrahydro-1H-1-benzoazepine-1-carbonyl]benzanilide and 4′-[5-(Substituted Methyl)-2,3-dihydro-1H-1benzoazepine-1-carbonyl]benzanilide Derivatives,”Chemical Pharmaceutical Bulletin, vol. 47, No. 3, 1999, pp. 329-339.
Tacconi, “Reazione di Schmidt su ossindolil e ossindolidenchetoni,”Gazzetta Chimica Italiana, vol. 98, No. 3, 1968, pp. 344-357 (with abstract).
Barberan et al., “Synthesis ofE- andZ-substituted methylene-3,4-dihydro-2H-1 benzopyrans by region- and stereocontrolled palladium-catalyzed intramolecular cyclization,”Tetrahedron Letters, vol. 42, No. 14, 2001.
Canoira et al., “Synthesis of Oxindole Derivatives fromN-Alkenyl-o-Chloranilides with Zero-Valent Nickel Complex,”Journal of Heterocyclic Chemistry, vol. 22, No. 6, 1985, pp. 1511-1518.
R. Di Fabio, “Enantiomerically Pure Tetrahydroquinoline Derivatives as In Vivo Potent Antagonists of the Glycine Binding Site Associated to the NMDA Receptor”,Bioorganic&Medicinal Chemistry Letters, vol. 13, No. 21, pp. 3863-3866, Nov. 2003.
Supplementary European Search Report dated Sep. 10, 2009.
Bannon et al., “Involvement of TRPV1 in the Regulation of Body Temprature in Rats and Mice”, Society for Neuroscience Abstract 30:890.24, pp. 1-2, 2004.
Gavva et al., “The Vanilloid Receptor TRPV1 is Tonically ActivatedIn Vitro and Involved in Body Temperature Regulation”, The Journal of Neuroscience, vol. 27, No. 13, pp. 3366-3374, Mar. 28, 2007.
Gavva, “Body-Temperature Maintenance as the Predominant Function of The Vanilloid Receptor TRPV1”, Trends in Pharmacological Science, vol. 29, No. 11, pp. 550-557, Sep. 19, 2008.
Swanson et al., “Identification and Biological Evaluation of 4(3-Trifluoromethylpyridin-2-yl)peperazine-1-carboxylic Acid (5-Trifluoromethylpyridin-2-yl)amide, a High Affinity TRPV1 (VR1) Vanilloid Receptor Antagonist”, J. Med. Chem., vol. 48, pp. 1857-1872, 2005.

Affiliated with

Also associated with

Rating

Heterocyclidene acetamide derivative does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Heterocyclidene acetamide derivative, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Heterocyclidene acetamide derivative will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-2720286